{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:59:37Z","timestamp":1777895977590,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI24\/01510"],"award-info":[{"award-number":["PI24\/01510"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC22\/00029"],"award-info":[{"award-number":["AC22\/00029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/01292"],"award-info":[{"award-number":["PI21\/01292"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT23\/00078"],"award-info":[{"award-number":["INT23\/00078"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM23\/00213"],"award-info":[{"award-number":["CM23\/00213"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nefroe.2026.501417","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T21:17:40Z","timestamp":1770844660000},"page":"501417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5474-0135","authenticated-orcid":false,"given":"Efra\u00edn","family":"Tatis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Ramos Terrades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Alejandra","family":"Gabald\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Agraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"L\u00f3pez-Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"N\u00fa\u00f1ez-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Le\u00f3n-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9stor","family":"Toapanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriol","family":"Bestard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.nefroe.2026.501417_bib0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: An update","volume":"4","author":"Rosenstock","year":"2019","journal-title":"Kidney Int Rep."},{"issue":"20","key":"10.1016\/j.nefroe.2026.501417_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026022","article-title":"Clinicopathologic features and treatment outcomes of patients with fibrillary glomerulonephritis: a case series","volume":"100","author":"Marinaki","year":"2021","journal-title":"Medicine (Baltimore)."},{"issue":"5","key":"10.1016\/j.nefroe.2026.501417_bib0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0272-6386(12)70290-1","article-title":"The fibrillary glomerulopathies","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"10.1016\/j.nefroe.2026.501417_bib0020","first-page":"110","article-title":"Fibrillary glomerulonephritis: a rare entity with unique ultrastructural characteristics","volume":"45","author":"Karanfilovski","year":"2023","journal-title":"J Bras Nefrol."},{"issue":"12","key":"10.1016\/j.nefroe.2026.501417_bib0025","article-title":"Fibrillary glomerulonephritis in a patient with Sj\u00f6gren\u2019s syndrome and primary biliary cholangitis: a case report and literature review","volume":"16","author":"Afonso","year":"2024","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.nefroe.2026.501417_bib0030","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort","volume":"14","author":"Andeen","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"10.1016\/j.nefroe.2026.501417_bib0035","first-page":"35","article-title":"Glomerulonefritis fibrilar e inmunotactoide","volume":"22","author":"Vera","year":"2005","journal-title":"An Med Interna."},{"issue":"4","key":"10.1016\/j.nefroe.2026.501417_bib0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.nefro.2023.05.003","article-title":"Glomerulonefritis fibrilar: \u00bfM\u00e1s frecuente de lo que parece? La importancia de la inmunohistoqu\u00edmica en el diagn\u00f3stico","volume":"44","author":"Viejo-Boyano","year":"2024","journal-title":"Nefrolog\u00eda."},{"issue":"3","key":"10.1016\/j.nefroe.2026.501417_bib0045","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr","year":"2019","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.nefroe.2026.501417_bib0050","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep."},{"issue":"9","key":"10.1016\/j.nefroe.2026.501417_bib0055","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.34067\/KID.0002532020","article-title":"Fibrillary glomerulonephritis and DnaJ homolog subfamily B member 9 (DNAJB9)","volume":"1","author":"Klomjit","year":"2020","journal-title":"Kidney360"},{"issue":"10","key":"10.1016\/j.nefroe.2026.501417_bib0060","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/ndt\/gfu189","article-title":"Rituximab treatment for fibrillary glomerulonephritis","volume":"29","author":"Hogan","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"10.1016\/j.nefroe.2026.501417_bib0065","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/ndt\/gfaa065","article-title":"Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study","volume":"36","author":"Erickson","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"10.1016\/j.nefroe.2026.501417_bib0070","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000455390","article-title":"Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis","volume":"45","author":"Schober","year":"2017","journal-title":"Am J Nephrol."},{"issue":"4","key":"10.1016\/j.nefroe.2026.501417_bib0075","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"10.1016\/j.nefroe.2026.501417_bib0080","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40620-020-00783-4","article-title":"Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker","volume":"34","author":"Liang","year":"2021","journal-title":"J Nephrol."},{"issue":"10","key":"10.1016\/j.nefroe.2026.501417_bib0085","article-title":"DNAJB9 fibrillary glomerulonephritis with membranous-like pattern: a case-based literature review","volume":"15","author":"Sabanis","year":"2023","journal-title":"Cureus."},{"issue":"5","key":"10.1016\/j.nefroe.2026.501417_bib0090","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11255-012-0236-7","article-title":"Fibrillary glomerulonephritis complicated by membranous nephropathy in a patient with tuberculosis","volume":"45","author":"Liu","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.nefroe.2026.501417_bib0095","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2012.13578","article-title":"Outcome of fibrillary glomerulonephritis: a retrospective study","volume":"142","author":"Kalbermatter","year":"2012","journal-title":"Swiss Med Wkly."},{"issue":"4","key":"10.1016\/j.nefroe.2026.501417_bib0100","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.kint.2017.10.022","article-title":"C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy","volume":"93","author":"Bomback","year":"2018","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.nefroe.2026.501417_bib0105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.34067\/KID.0006172020","article-title":"Focal segmental glomerulosclerosis, risk factors for end-stage kidney disease, and response to immunosuppression","volume":"2","author":"Forster","year":"2021","journal-title":"Kidney360"}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251426000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:11:13Z","timestamp":1777623073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251426000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2013251426000222"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501417","relation":{},"ISSN":["2013-2514"],"issn-type":[{"value":"2013-2514","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibrillary glomerulonephritis: clinicopathological characteristics and treatment in a spanish tertiary center","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2026.501417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2025.501417","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501417"}}